Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boehringer Ingelheim
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
diagnosis of essential arterial hypertension (BP\>140/90 mm HG or BP\>130/80 mm Hg for diabetic patients)
at least one additional cardiovascular risk factor and/or known single or multiple end organ damage and/or previous cardiovascular disease
You may not be if
hypersensitivity to the active substance or to any of the excipients in any ACE inhibitor or angiotensin receptor blocker (ARB) available on the local market, as prescribed in the SPC
pregnancy and lactation
diseases involving biliary obstruction
severe liver impairment
severe hypertension
malignant hypertension
secondary hypertension
patients age under 18 years
Clareo Health | Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients
